CELLULAR AND EXTRACELLULAR MYELOPEROXIDASE IN PYOGENIC INFLAMMATION

Authors:
  • PBPP BRADLEY
    PP BRADLEY
  • RCRD CHRISTENSEN
    RD CHRISTENSEN
  • GRG ROTHSTEIN
    G ROTHSTEIN

  • 1 January 1982
    • journal article
    • research article
    • Vol. 60  (3) , 618-622
    • PMID:6286012
Abstract
The effect of in vitro phagocytosis and in vivo inflammation on the myeloperoxidase (MPO) content of functioning [human or rat] neutrophils and on the ability of these cells to export active MPO into the extracellular environment was studied. After ingestion of staphylococci [Staphylococcus aureus], neutrophils retained 52% of their MPO and released 8% into the medium in active form; the remaining 40% of their MPO could no longer be detected. During bacterial infection induced by intradermally injecting staphylococci, neutrophils harvested from minced infected lesions contained 52% of the MPO of circulating neutrophils that had not reached the lesions. Extracellular fluid from the lesions contained active MPO secreted by the neutrophils, and concentrations of 10-45 U/ml were detected. Evidently, functioning neurophils can lose approximately half of their MPO. In vitro, 4-8% of neutrophilic MPO appears in the extracellular space and 40% is inactivated. In vivo, the MPO content of inflammatory neutrophils also decreases and MPO appears in the extracellular fluid in active form where it is available to participate in a variety of physiologic processes.